U. C. Rezek

Beneficial effects of colchicine for moderate to severe COVID-19: an interim analysis of a randomized, double-blinded, placebo controlled clinical trial

F. Cunha, J. Alves-Filho, P. Louzada-Junior, 2020, medRxiv.

Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical trial

F. Cunha, J. Alves-Filho, P. Louzada-Junior, 2021, RMD Open.

Colchicine reduces the activation of NLRP3 inflammasome in COVID-19 patients

C. Del-Ben, P. Louzada-Junior, R. Luppino-Assad, 2023, Inflammation research : official journal of the European Histamine Research Society ... [et al.].

Telemedicine in Cardiology for Outpatient Follow-Up of Patients at High Cardiovascular Risk in Response to the COVID-19 Pandemic.

B. Maciel, A. Schmidt, A. Pazin Filho, 2021, Arquivos brasileiros de cardiologia.